Does ROFECOXIB Cause Interstitial lung disease? 5 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Interstitial lung disease have been filed in association with ROFECOXIB. This represents 0.4% of all adverse event reports for ROFECOXIB.
5
Reports of Interstitial lung disease with ROFECOXIB
0.4%
of all ROFECOXIB reports
0
Deaths
4
Hospitalizations
How Dangerous Is Interstitial lung disease From ROFECOXIB?
Of the 5 reports, 4 (80.0%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROFECOXIB. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does ROFECOXIB Cause?
Drug hypersensitivity (404)
Drug ineffective (319)
Depression (198)
Fatigue (194)
Rheumatoid arthritis (188)
Anxiety (187)
Diarrhoea (179)
Dizziness (172)
Abdominal pain (170)
Malaise (166)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which ROFECOXIB Alternatives Have Lower Interstitial lung disease Risk?
ROFECOXIB vs ROFLUMILAST
ROFECOXIB vs ROLAPITANT
ROFECOXIB vs ROMIDEPSIN
ROFECOXIB vs ROMIPLOSTIM
ROFECOXIB vs ROMOSOZUMAB